Morgan Stanley Cardiovascular Systems Inc Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$13.31 - $19.86 $1.68 Million - $2.5 Million	-126,101 Reduced 15.55%	684,600 $13.6 Million
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $860,026 - $1.02 Million	67,506 Added 9.08%	810,701 $11 Million
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $469,074 - $622,893	36,278 Added 5.13%	743,195 $10.3 Million
Q2 2022 Oct 27, 2022	BUY	$13.53 - $23.34 $1.77 Million - $3.06 Million	131,010 Added 22.75%	706,917 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $1.77 Million - $3.06 Million	131,010 Added 22.75%	706,917 $10.2 Million
Q1 2022 Oct 27, 2022	SELL	$16.14 - $22.6 $2.11 Million - $2.96 Million	-131,010 Reduced 18.53%	575,907 $13 Million
Q1 2022 May 13, 2022	SELL	$16.14 - $22.6 $1.38 Million - $1.94 Million	-85,665 Reduced 12.95%	575,907 $13 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $8.97 Million - $17.7 Million	481,326 Added 267.04%	661,572 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$32.83 - $43.0 $5.92 Million - $7.75 Million	180,246 New	180,246 $5.92 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.